AQST FY 2018 Earnings — Aquestive Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

AQSTAquestive Therapeutics, Inc.

$427M

FY 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$67M+0.8% YoY

Gross Profit

$46M68.9% margin

Operating Income

-$49M-72.6% margin

Net Income

-$61M-91.0% margin

EPS (Diluted)

$-2.96

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$15M

Stock-Based Comp.

$30M

Balance Sheet

Total Assets

$87M

Total Liabilities

$77M

Stockholders' Equity

$10M

Cash & Equivalents

$61M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$67M	$67M	+0.8%
Gross Profit	$46M	$47M	-1.4%
Operating Income	-$49M	-$113,000	-43204.4%
Net Income	-$61M	-$9M	-586.3%